ARPA-H Director Dr. Renee Wegrzyn to Keynote at the 18th Annual Non-Dilutive Funding Summit
NIA Expert to Present at NDFS 2023
UPDATE: Congress on Track to Reauthorize the SBIR and STTR Programs
Update on Biden’s $2-Billion Biotechnology Boost
SBIR/STTR Programs Could Expire Sept. 30
Biden Establishes National Biotechnology and Biomanufacturing Initiative with Executive Order
Is Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
BioPharm America, an EBD event, Sept 28-29, Boston (& Virtual)
BioForward, Sept 27, Oxford
How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
Biofuture, a Demy-Colton Event
The HealthTech Investment Forum & Biotech in Europe Forum, Sept. 20-22, Basel
Recent Posts
BioFuture, October 27-28, 2026, NYCAugust 2, 2026 - 6:59 am
RESI Boston, September 22-23, 2026, Boston, USAJuly 30, 2026 - 8:42 am
LSX USA Congress, September 23-24, 2026, Boston, USAJuly 30, 2026 - 8:37 am
The 2026 Mid-Year Non-Dilutive Funding Landscape ReportJuly 20, 2026 - 9:44 am
SBIR Is Back — Here’s What Changed and What You Need to Do NowJune 16, 2026 - 8:03 am